Asthma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who have a formal diagnosis of asthma recorded in their medical records
- People whose asthma has been classified as severe, with specific blood and breathing test results showing high levels of inflammation markers (a breath test result above 25 ppB for a substance called FeNO, and blood or mucus tests showing elevated levels of certain immune cells called eosinophils — confirm specific thresholds with trial site)
- People who have previously been treated with a type of medication called monoclonal antibodies for asthma, provided enough time has passed since the last dose (at least two half-lives of the medication or one month, whichever is longer)
Who may not be able to join:
- People who are pregnant, as confirmed by a blood test
- People whose airways have physical abnormalities that would make a camera examination of the lungs (bronchoscopy) unsafe or impossible
- People who have other serious lung conditions such as bronchiectasis, COPD, pulmonary fibrosis, emphysema, cystic fibrosis, lung cancer, or known parasitic infections
- People who have conditions that can cause asthma-like symptoms and high eosinophil levels, such as Churg-Strauss syndrome, allergic bronchopulmonary aspergillosis, or hypereosinophilic syndrome
- People with a mental health condition that would prevent them from fully understanding what participation in the study involves
- People with other significant health conditions, as assessed by the trial's medical committee
- People who have had an asthma flare-up within the four weeks before the first main trial visit
- People with immune system disorders or who are taking immunosuppressive medications (such as cyclosporine), or who are currently receiving or recently received biological treatments for asthma (such as mepolizumab, omalizumab, or benralizumab) within the required washout period
- People with a history of drug or alcohol misuse
- People who currently smoke, or who stopped smoking less than six months ago and have a significant smoking history (more than 10 pack years — confirm this measure with the trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +43140400
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Effect of Dupilumab treatment on mucus plugging in patients with severe eosinophilic asthma
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.